This story is currently available in англійська only — a translation isn't ready yet.
Sanfilippo families urge ministers to fund £2.95m gene therapy approved in US
Parents of four children with childhood dementia say they are left in limbo over access to FAYUVI, approved in the US in September, ahead of World Sanfilippo Awareness Day on 16 November.

Families of children with Sanfilippo syndrome are pressing the government to fund research and help them access treatment in the UK, saying their children "don't have time to wait".
Georgia Nonas, 29, has launched a petition calling on ministers to fund FAYUVI (rebisufligene etisparvovec-hopf), which was approved in the US in September. Her son Cody Carroll, 9, was three when he was diagnosed with type A Sanfilippo and was given little hope because no treatment was available.
"These children don't have time to wait," Ms Nonas said. She added that families are left "in limbo" once a treatment is approved, and that "where you live is determining if these children are going to live or die".
Sanfilippo syndrome is a rare inherited disorder that mainly affects the brain and nervous system. Better known as childhood dementia, it can gradually take away skills such as speaking, walking and eating independently. Life expectancy varies; some children are not expected to live past their teens.
Researchers estimated that 204 people in the UK die from conditions that cause childhood dementia per year, similar in scale to 240 cancer deaths recorded among UK children aged 0-14.
Tammy McDaid, 34, said her son Tate Flaherty, 5, who has type A, was officially diagnosed in April 2025, after childhood dementia was first mentioned to her in March 2024 and doctors ruled out Sanfilippo 13 months later, in April 2025. She said one trial she applied to took only under-fives, and Tate had turned five weeks earlier. Ms McDaid, from Swansea, said a multidisciplinary team meeting did not happen until May 2026, after she broke down in a cardiology appointment.
Emily, 34, and Gus Forrester, 36, said their daughter Leni, 3, was diagnosed with type B days before her second birthday. "There's no treatment, no cure, go home and love your child," Mr Forrester said of what they were told. Type B currently has no approved cure or disease-modifying treatment anywhere in the world, though clinical trials are under way in the UK and the US. The family are from Sevenoaks, Kent.
The FDA-approved gene therapy costs $3.95million, approximately £2.95million. Bethany Gordon, 33, and Daniel Pearson, 40, whose two-year-old son Kole Pearson was diagnosed with type A in April this year, making him the youngest in the UK currently diagnosed, have raised over £100,000. Ms Gordon, from Ellesmere Port, said fundraising had taken a toll on her mental health.
The appeals come ahead of World Sanfilippo Awareness Day on 16 November.
Sources — how we know this
- PrimaryDaily Mirror — News